Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Disc Medicine, Inc.IRON · Entity 2273 | Chief Legal Officer | August 06, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Disc Medicine, Inc.
Report date August 06, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,324 |
Last balance in matching sequence
After 2026-08-06 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-08-06 · Exercise / conversion · Acquired 5,000 · Balance 57,324 F1: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2: Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026. Row 2 · 2026-08-06 · Sale · Disposed 5,000 · Balance 52,324 F1: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2: Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.69 · Expires 2032-02-07 | Direct | 49,804 |
Reported balance
After 2026-08-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-06 · Exercise / conversion · Disposed 5,000 · Balance 49,804 F1: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F3: The shares underlying this option are fully vested and exercisable as of the date hereof. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.
F2: Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026.
F3: The shares underlying this option are fully vested and exercisable as of the date hereof.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2026 Filed Aug 7, 2026 21:32 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0001193125-26-340543 · ownership.xml · derivative · entry 3 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,804 Underlying: Common Stock · 5,000 shares Expires 2032-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 06, 2026 Filed Aug 7, 2026 21:32 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 5,000 | $80.00 | $400,000.00 |
DisclosureSEC source: 0001193125-26-340543 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,324 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2 · balance_after: Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026. Read SEC document |
| August 06, 2026 Filed Aug 7, 2026 21:32 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 5,000 | $14.69 | $73,450.00 |
DisclosureSEC source: 0001193125-26-340543 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2 · balance_after: Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 21:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,649 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · derivative · entry 6 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,804 Underlying: Common Stock · 1,649 shares Expires 2032-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 21:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,649 | $75.00 | $123,675.00 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 4 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,173 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 21:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 1,649 | $14.69 | $24,223.81 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 851 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · derivative · entry 5 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,453 Underlying: Common Stock · 851 shares Expires 2032-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 851 | $75.00 | $63,825.00 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,173 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:49 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 851 | $14.69 | $12,501.19 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · derivative · entry 5 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,304 Underlying: Common Stock · 7,500 shares Expires 2032-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F5 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 500 | $71.62 | $35,811.00 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 4 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,173 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.45 to $71.81, inclusive. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,600 | $70.73 | $113,161.12 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,673 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.40 to $71.38, inclusive. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 5,400 | $69.94 | $377,688.42 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,273 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.35 to $70.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 7,500 | $14.69 | $110,175.00 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 02:20 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 2,853 | $62.86 | $179,339.58 |
DisclosureSEC source: 0001193125-26-055652 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,173 F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 00:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantStock Option (Right to Buy) · Derivative | 25,500 | $0.00 Strike: $74.75 | $0.00 |
DisclosureSEC source: 0001193125-26-047206 · ownership.xml · derivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 25,500 shares Expires 2036-02-09 F3 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 00:50 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-047206 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,026 F1 · shares: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2027, subject to the Reporting Person's continued service on each such vesting date. F2 · balance_after: Includes 233 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on January 30, 2026. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 23:55 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0001193125-26-018320 · ownership.xml · derivative · entry 3 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,270 Underlying: Common Stock · 1,000 shares Expires 2032-12-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 23:55 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,000 | $69.74 | $69,740.00 |
DisclosureSEC source: 0001193125-26-018320 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,793 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 23:55 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 1,000 | $13.50 | $13,500.00 |
DisclosureSEC source: 0001193125-26-018320 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 01:02 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0001193125-26-003075 · ownership.xml · derivative · entry 5 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,270 Underlying: Common Stock · 6,500 shares Expires 2032-12-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F6 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 01:02 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,157 | $79.27 | $91,717.70 |
DisclosureSEC source: 0001193125-26-003075 · ownership.xml · nonDerivative · entry 4 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,793 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.10 to $79.49, inclusive. F2 · balance_after: Includes 210 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 01:02 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 4,993 | $78.62 | $392,569.13 |
DisclosureSEC source: 0001193125-26-003075 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,950 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.09 to $79.07, inclusive. F2 · balance_after: Includes 210 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 01:02 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 350 | $77.67 | $27,184.92 |
DisclosureSEC source: 0001193125-26-003075 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,943 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.09 to $78.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (5) to this Form 4. F2 · balance_after: Includes 210 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 01:02 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 6,500 | $13.50 | $87,750.00 |
DisclosureSEC source: 0001193125-26-003075 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. F2 · balance_after: Includes 210 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2025. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 00:36 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,161 | $54.58 | $63,367.38 |
DisclosureSEC source: 0000950170-25-024476 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,583 F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units granted on January 10, 2024 and previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · balance_after: Includes 215, 209 and 285 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on January 31, 2024, July 31, 2024 and January 31, 2025, respectively. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:43 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantStock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $54.71 | $0.00 |
DisclosureSEC source: 0000950170-25-019101 · ownership.xml · derivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2035-02-09 F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2025, subject to the Reporting Person's continuted service on each such vesting date. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:43 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-019101 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,035 F1 · shares: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:18 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0000950170-25-013714 · ownership.xml · derivative · entry 4 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,804 Underlying: Common Stock · 7,500 shares Expires 2032-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024. F4 · derivative.exercise_date: 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:18 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,813 | $56.01 | $101,542.32 |
DisclosureSEC source: 0000950170-25-013714 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,035 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.28, inclusive. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:18 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 5,687 | $55.40 | $315,031.37 |
DisclosureSEC source: 0000950170-25-013714 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,848 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.87 to $55.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:18 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 7,500 | $14.69 | $110,175.00 |
DisclosureSEC source: 0000950170-25-013714 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:56 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0000950170-25-002373 · ownership.xml · derivative · entry 5 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,304 Underlying: Common Stock · 7,500 shares Expires 2032-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024. F5 · derivative.exercise_date: 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:56 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 2,100 | $64.13 | $134,682.87 |
DisclosureSEC source: 0000950170-25-002373 · ownership.xml · nonDerivative · entry 4 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,035 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.83 to $64.54, inclusive. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:56 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 1,400 | $62.95 | $88,135.46 |
DisclosureSEC source: 0000950170-25-002373 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,135 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.56 to $63.48, inclusive. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:56 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 4,000 | $61.96 | $247,839.60 |
DisclosureSEC source: 0000950170-25-002373 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,535 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.52 to $62.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:56 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 7,500 | $14.69 | $110,175.00 |
DisclosureSEC source: 0000950170-25-002373 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2024. Read SEC document |
| January 10, 2024 Filed Mar 2, 2024 00:39 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantStock Option (Right to Buy) · Derivative | 21,050 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0000950170-24-024193 · ownership.xml · derivative · entry 2 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,050 Underlying: Common Stock · 21,050 shares Expires 2034-01-09 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on January 10, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 10, 2024 Filed Mar 2, 2024 00:39 UTC | Disc Medicine, Inc. IRON · Entity 2273 | GrantCommon Stock | 14,035 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024193 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,035 Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0000950170-23-066117 · ownership.xml · derivative · entry 4 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,804 Underlying: Common Stock · 10,000 shares Expires 2032-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F4 · derivative.exercise_date: 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 9,900 | $51.75 | $512,299.26 |
DisclosureSEC source: 0000950170-23-066117 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.27 to $52.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 100 | $50.34 | $5,034.00 |
DisclosureSEC source: 0000950170-23-066117 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,900 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.25 to $50.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:15 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 10,000 | $14.69 | $146,900.00 |
DisclosureSEC source: 0000950170-23-066117 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. Read SEC document |
| November 15, 2023 Filed Nov 15, 2023 22:00 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,900 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0000950170-23-064228 · ownership.xml · derivative · entry 4 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,804 Underlying: Common Stock · 4,900 shares Expires 2032-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F4 · derivative.exercise_date: 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 22:00 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 787 | $51.05 | $40,174.54 |
DisclosureSEC source: 0000950170-23-064228 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.01 to $51.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 22:00 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 4,113 | $50.53 | $207,837.29 |
DisclosureSEC source: 0000950170-23-064228 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 787 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.01 to $51.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 22:00 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 4,900 | $14.69 | $71,981.00 |
DisclosureSEC source: 0000950170-23-064228 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 23:22 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0000950170-23-060503 · ownership.xml · derivative · entry 3 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,704 Underlying: Common Stock · 100 shares Expires 2032-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F2 · derivative.exercise_date: 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 23:22 UTC | Disc Medicine, Inc. IRON · Entity 2273 | SaleCommon Stock | 100 | $50.00 | $5,000.00 |
DisclosureSEC source: 0000950170-23-060503 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 23:22 UTC | Disc Medicine, Inc. IRON · Entity 2273 | Exercise / conversionCommon Stock | 100 | $14.69 | $1,469.00 |
DisclosureSEC source: 0000950170-23-060503 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.